Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

CONVINCE in the context of existing evidence on haemodiafiltration

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Publication Information:
      Oxford University Press
    • Publication Date:
      2022
    • Collection:
      UNSW Sydney (The University of New South Wales): UNSWorks
    • Abstract:
      Haemodiafiltration (HDF) provides a greater removal of larger solutes and protein-bound compounds than conventional high-flux haemodialysis (HD). There are indications that the patients receiving the highest convection volumes of HDF result in improved survival compared with HD. However, the comparative efficacy of HDF versus HD remains unproven. Here we provide a comparative account of the methodology and aims of ‘the comparison of high-dose HDF with high-flux HD’ (CONVINCE) study in the context of the totality of evidence and how this study will contribute to reaching a higher level of certainty regarding the comparative efficacy of HDF versus HD in people with end-stage kidney disease.
    • File Description:
      application/pdf
    • Relation:
      http://hdl.handle.net/1959.4/unsworks_82815; https://unsworks.unsw.edu.au/bitstreams/f2f95bff-e700-456d-8428-6dbe51dfd365/download; https://doi.org/10.1093/ndt/gfac019
    • Accession Number:
      10.1093/ndt/gfac019
    • Online Access:
      http://hdl.handle.net/1959.4/unsworks_82815
      https://unsworks.unsw.edu.au/bitstreams/f2f95bff-e700-456d-8428-6dbe51dfd365/download
      https://doi.org/10.1093/ndt/gfac019
    • Rights:
      open access ; https://purl.org/coar/access_right/c_abf2 ; CC BY-NC ; https://creativecommons.org/licenses/by-nc/4.0/ ; free_to_read ; This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
    • Accession Number:
      edsbas.3B937820